Path: utzoo!mnetor!tmsoft!torsqnt!jarvis.csri.toronto.edu!rutgers!usc!henry.jpl.nasa.gov!elroy.jpl.nasa.gov!ucla-cs!phil@wubios.WUstl.EDU
From: phil@wubios.WUstl.EDU (J. Philip Miller)
Newsgroups: sci.med.aids
Subject: Re: Cost of AZT
Summary: Not public information
Message-ID: <27241@shemp.CS.UCLA.EDU>
Date: 19 Sep 89 19:17:28 GMT
References: <27222@shemp.CS.UCLA.EDU>
Sender: news@CS.UCLA.EDU
Reply-To: phil@wubios.WUstl.EDU (J. Philip Miller)
Organization: Washington University (St. Louis)
Lines: 21
Approved: aids@cs.ucla.edu
Archive-number: 1247

In article <27222@shemp.CS.UCLA.EDU> asuvax!stjhmc!f14.n280.z1.fidonet.org!Hard.One@ncar.UCAR.EDU (Hard One) writes:
>Does anyone know the actual cost of manufacturing AZT now?  Since the drug had  
>already been FDA approved, I can not understand the outrageous price being  
>charged for the drug.  I have heard that the actual cost is five cents per  
>dose.  Can someone supply the correct figure and a published source if  
>possible.
>

In the last several days Burrows Welcome has announced a 20% reduction in the
wholesale cost of AZT.  Specifically mentioned in several of the news accounts
of this was the fact that the manufacturing costs were NOT public information.
In general the R&D costs and the marketing costs dominate the selling price
rather than the manufacturing costs.

-phil

-- 
     J. Philip Miller, Professor, Division of Biostatistics, Box 8067
	 Washington University Medical School, St. Louis MO 63110
phil@wubios.WUstl.edu - Internet  (314) 362-3617   phil@wubios.wustl - bitnet
uunet!wucs1!wubios!phil - UUCP              C90562JM@WUVMD - alternate bitnet